Metraipolis › archive › dc_cc7062cf63f7

Labetalol, Nifedipine, and Methyldopa for the Management of Hypertensive Disorders in Pregnancy in Iran: A Cost-Effectiveness Analysis — Europe PMC PMID:42577362

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42577362
DOI
10.1002/hsr2.72968
License (as archived)
solo-consultazione
Archived
2026-10-16T22:30:05.043Z
SHA-256 of the archived text
244fc5157bc3383ceea5ac6e9e8f596757f2b5554e63abc0e66a22d2abf398d6
Stable URL of this page
https://metraipolis.com/documento/dc_cc7062cf63f7

How to cite

Labetalol, Nifedipine, and Methyldopa for the Management of Hypertensive Disorders in Pregnancy in Iran: A Cost-Effectiveness Analysis — Europe PMC PMID:42577362 — Europe PMC (en), https://europepmc.org/article/MED/42577362 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cc7062cf63f7 (Metraipolis archive dc_cc7062cf63f7, sha256 244fc5157bc3383ceea5ac6e9e8f596757f2b5554e63abc0e66a22d2abf398d6)
BibTeX
@misc{dccc7062cf63f7,
  title = {Labetalol, Nifedipine, and Methyldopa for the Management of Hypertensive Disorders in Pregnancy in Iran: A Cost-Effectiveness Analysis — Europe PMC PMID:42577362},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42577362},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cc7062cf63f7; sha256 244fc5157bc3383ceea5ac6e9e8f596757f2b5554e63abc0e66a22d2abf398d6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42577362. Agents can read the archived copy with the MCP tool read_document.